Product Program year 2025 Source: CMS Open Payments

Allevyn Heel 10.5Cm X 13.5Cm CTN 5

Device Exudate Management

PDI 05000223426705

Open in the dashboard

General payments

$279,016

1,264 payments

Research payments

$0

0 payments

Through program year 2025, $279,016 in general payments and $0 in research payments were reported against Allevyn Heel 10.5Cm X 13.5Cm CTN 5 (Exudate Management).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2025 General $67,234 541
2024 General $36,230 151
2023 General $112,376 395
2022 General $63,176 177

Breakdown

Who paid General payments · program years 2022–2025
  1. Smith+Nephew, Inc. $279,016 1,264 payments
Top recipients General payments · program year 2025
  1. Heather Przybyl Registered Nurse, Critical Care Medicine · Phoenix, AZ $21,453 32% · 54 payments
  2. Catherine Milne Nurse Practitioner · Plymouth, CT $6,601 10% · 14 payments
  3. Kelly McFee Nurse Practitioner, Family · Sunnyside, WA $5,876 9% · 12 payments
  4. Annmarie Vilkins Obstetrics & Gynecology · Ann Arbor, MI $5,647 8% · 4 payments
  5. Paul Kim Podiatrist, Foot & Ankle Surgery · Dallas, TX $3,544 5% · 5 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Registered Nurse, Critical Care Medicine Registered Nurse $21,453 33% · 1 practitioner
  2. Nurse Practitioner, Family Nurse Practitioner $7,561 12% · 34 practitioners
  3. Nurse Practitioner $6,920 11% · 13 practitioners
  4. Obstetrics & Gynecology $6,018 9% · 15 practitioners
  5. Podiatrist, Foot & Ankle Surgery Podiatrist $3,975 6% · 16 practitioners

The top 5 of 53 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Arizona $24,215 36% · 5 recipients
  2. Texas $8,083 12% · 10 recipients
  3. Connecticut $6,618 10% · 2 recipients
  4. Washington $6,100 9% · 11 recipients
  5. Michigan $5,893 9% · 6 recipients

The top 5 of 37 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

1,264 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record